Wednesday, February 10, 2010, 6:07pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Omeros Corporation (OMER)

At 5:00AM SGT: 5.69 USD   0.00 (0.00%)  
 MORE ON OMER 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Omeros Corporation (NGM:OMER) Delayed quote dataEdit
Last Trade:5.69 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:5.69
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:11.80
Day's Range:N/A - N/A
52wk Range:5.27 - 9.49
Volume:0
Avg Vol (3m):45,754
Market Cap:121.04M
P/E (ttm):N/A
EPS (ttm):-7.48
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m 
Use Y! Toolbar to track stocks
 Add OMER to Portfolio   Download Data

 HEADLINES 
•Omeros Announces National Institute on Drug Abuse's Support for Phase 2 Clinical Study in Addiction Program
PR Newswire (Thu, Jan 28)
•After A Sluggish Year, VCs Eye Improvement
Investor's Business Daily (Sat, Jan 9)
•IPO comeback in 2009 sets stage for busy 2010
AP (Fri, Jan 1)
•The Worst IPOs Of 2009
at Investopedia (Thu, Dec 17)
•Worst IPOs of 2009: Biggest Stock Flops
at TheStreet.com (Tue, Dec 15)
•OMEROS CORP Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Wed, Dec 9)
•Coverage initiated on Omeros by Needham
Briefing.com (Tue, Dec 1)
•New Star Analyst Rankings for Omeros Corporation
StarMine (Sun, Nov 22)
•OMEROS CORP Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Fri, Nov 20)
•Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights
PR Newswire (Fri, Nov 20)
More Headlines for OMER...
 ANALYST 
EPS Est (next year) (Dec-09) :-1.44
EPS Est (in 2 years) (Dec-10) :-1.41
Avg Rec (current)*:1.6
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Omeros Corporation, a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing products on inflammation and disorders of the central nervous system.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices